AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 FEB 20 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that a pneumcoccal protein can induce potent antibacterial immune responses.
"Pneumococcal surface adhesin A (PsaA), a common protein expressed on all 90 pneumococcal serotypes, is a vaccine candidate," explained Dr. Scott E. Johnson and colleagues at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia.
PsaA peptides were highly immunogenic in a murine model, Johnson and coauthors reported.
The researchers evaluated the efficacy of three PsaA peptides in mice exposed to pneumococcal pathogens. They tested the effects of lipidating these peptides and compared mono- and multipeptide constructs, according to their report.
All of the PsaA peptide formulations induced the production of antibodies that inhibited nasopharyngeal carriage of pneumococcal serotypes 2, 4, and 6B, study data showed. The best results were obtained with lipidated and/or multipeptide constructs, which reduced pneumococcal carriage by up to 98%.
Nonlipidated and/or monopeptides also reduced bacterial carriage by a large ...